Gene: BAZ1B
Official Full Name: bromodomain adjacent to zinc finger domain 1Bprovided by HGNC
Gene Summary: This gene encodes a member of the bromodomain protein family. The bromodomain is a structural motif characteristic of proteins involved in chromatin-dependent regulation of transcription. This gene is deleted in Williams-Beuren syndrome, a developmental disorder caused by deletion of multiple genes at 7q11.23. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33637 | BAZ1B Knockout cell line (HeLa) | Human | BAZ1B | 1:3~1:6 | Negative | Online Inquiry |
KO33638 | BAZ1B Knockout cell line (HCT 116) | Human | BAZ1B | 1:2~1:4 | Negative | Online Inquiry |
KO33639 | BAZ1B Knockout cell line (HEK293) | Human | BAZ1B | 1:3~1:6 | Negative | Online Inquiry |
KO33640 | BAZ1B Knockout cell line (A549) | Human | BAZ1B | 1:3~1:4 | Negative | Online Inquiry |
BAZ1B Gene Knockout Cell Lines represent a revolutionary tool designed for researchers focused on the intricate roles of the BAZ1B gene in various biological processes, including gene regulation and cellular stress response. These genetically engineered cell lines are created through precise CRISPR-Cas9 technology, ensuring accurate and complete knockout of the BAZ1B gene, which encodes a protein integral to chromatin remodeling and cellular signaling pathways.
The primary function of these cell lines lies in their ability to facilitate the study of BAZ1B’s impact on gene expression, cellular differentiation, and response to external stimuli. By providing a system devoid of the BAZ1B gene, researchers can explore its biological functions and the resulting phenotypic changes, shedding light on its potential implications in diseases such as cancer and genetic disorders.
Scientifically, the BAZ1B Gene Knockout Cell Lines serve as an invaluable asset in both academic and clinical research settings. Their application extends to drug discovery, functional genomics, and the burgeoning field of personalized medicine, where understanding the intricate mechanisms of genes like BAZ1B can lead to targeted therapeutic strategies.
What sets our BAZ1B Gene Knockout Cell Lines apart from alternatives is their high specificity and reproducibility, owing to state-of-the-art gene editing techniques. This precision minimizes off-target effects, ensuring that experimental results are both reliable and applicable. Additionally, our product is rigorously validated, with comprehensive documentation supporting its utility in various assay systems.
For researchers, clinicians, and companies alike, the BAZ1B Gene Knockout Cell Lines offer a powerful avenue for advancing our understanding of gene function and disease pathways. With the expertise and commitment to quality that our company embodies, we provide not just a product, but a reliable partnership in scientific discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.